Table 2.
Clinical and pathological data: Association between clinical data and HCC recurrence. Fisher’s exact test and Pearson’s chi-square (chi-square without Yates correction) were used, as appropriate.
| Clinical and pathological data | Overall | No HCC Recurrence | HCC Recurrence | p-Value |
|---|---|---|---|---|
| n | 71 | 53 | 18 | |
| Male Gender, no. (%) | 59 (83.1) | 44 (83.0) | 15 (83.3) | 1.000 |
| Age, median [IQR] | 59.00 [53.5, 63.0] | 59.0 [52.0, 63.0] | 59.0 [56.0, 61.8] | 0.706 |
| HCC etiology, no (%) | 0.216 | |||
| HBV | 14 (19.7) | 13 (24.5) | 1 (5.6) | |
| HBV+HCV | 1 (1.4) | 1 (1.9) | 0 (0.0) | |
| HCV | 49 (69.0) | 35 (66.0) | 14 (77.8) | |
| Other | 7 (9.9) | 4 (7.5) | 3 (16.7) | |
| MELD, median [IQR] | 12.00 [9.0, 15.0] | 12.00 [9.0, 15.0] | 11.5 [9.0, 14.8] | 0.801 |
| HCC nodules, no. (%) | 0.128 | |||
| 1 | 23 (32.4) | 19 (35.8) | 4 (22.2) | |
| 2 | 19 (26.8) | 16 (30.2) | 3 (16.7) | |
| 3+ | 29 (40.8) | 18 (34.0) | 11 (61.1) | |
| Largest nodule size (cm), median [IQR] | 2.50 [2.0, 3.5] | 2.5 [1.7, 3.4] | 2.7 [2.2, 3.8] | 0.331 |
| Histologic grade G2–G3, no. (%) | 31 (43.7) | 23 (43.4) | 8 (44.4) | 0.938 |
| Vascular invasion, no. (%) | 29 (40.8) | 20 (37.7) | 9 (50.0) | 0.360 |
| TNM (%) | 0.047 | |||
| T1 | 10 (14.1) | 10 (18.9) | 0 (0.0) | |
| T2–T3 | 42 (59.2) | 32 (60.4) | 10 (55.6) | |
| NA | 19 (26.8) | 11 (20.8) | 8 (44.4) | |
| Milan = Out (%) | 44 (62.0) | 36 (67.9) | 8 (44.4) | 0.076 |